Cathay Biotech Stock Hits Day Low of CNY 51.28 Amid Price Pressure

Cathay Biotech, Inc., a prominent player in the specialty chemicals sector, experienced a notable decline of 3.27% on March 5, 2026, marking a challenging day for the stock. During intraday trading, the stock reached a low of CNY 51.28, reflecting broader market pressures. Over the past week, Cathay Biotech has seen a decrease of 4.93%, contrasting with a slight gain of 0.41% in the China Shanghai Composite. The company's performance over the past month also shows a decline of 4.96%, while its year-to-date performance stands at a modest 3.82%, slightly outperforming the composite index's 2.85%. Despite a year-over-year return of 7.62%, which is significantly lower than the composite's 22.49%, Cathay Biotech has reported positive results for the last four consecutive quarters. However, the company faces challenges with a low Return on Capital Employed (ROCE) of 8.99% and a Return on Equity (ROE) of 3.01%. The stock's current valuation reflects a Price to Book ratio of 1.76 and a dividend yield of 0.75%, indicating a cautious outlook amid fluctuating market conditions.